percp cyanine5 5 anti human cd14 antibody Search Results


94
Elabscience Biotechnology percp cyanine5 5 anti human cd14 antibody
MDSC subsets in KRAS-mutated PNETs (A) Representative flow cytometry plots and histogram overlays demonstrate elevated CD11b + cell proportions in KRAS G12C patient blood samples compared to wild-type KRAS tumors and healthy controls. (B) Quantification shows a slight elevation in <t>CD14</t> + cell frequency compared to wild-type KRAS, alongside a marked enrichment relative to healthy controls. (C) A moderate rise in CD15 + cell frequency in KRAS G12C samples versus wild-type KRAS, with a pronounced elevation compared to normal baseline levels. (D) Statistical comparisons confirm a significant increase in CD33 + cell populations relative to both wild-type KRAS and healthy controls.
Percp Cyanine5 5 Anti Human Cd14 Antibody, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/percp+cyanine5+5+anti+human+cd14+antibody/PerCP%2FCyanine5%2E5+Anti-Human+CD14+Antibody/pmc12794431-13-0-6
Average 94 stars, based on 1 article reviews
percp cyanine5 5 anti human cd14 antibody - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier


N/A
The 61D3 antibody is specific for human CD14 a 53 55 kDa GPI anchored glycoprotein CD14 is highly expressed on monocytes and to a lesser extent on interfollicular macrophages and some dendritic cells Together with
  Buy from Supplier

Image Search Results


MDSC subsets in KRAS-mutated PNETs (A) Representative flow cytometry plots and histogram overlays demonstrate elevated CD11b + cell proportions in KRAS G12C patient blood samples compared to wild-type KRAS tumors and healthy controls. (B) Quantification shows a slight elevation in CD14 + cell frequency compared to wild-type KRAS, alongside a marked enrichment relative to healthy controls. (C) A moderate rise in CD15 + cell frequency in KRAS G12C samples versus wild-type KRAS, with a pronounced elevation compared to normal baseline levels. (D) Statistical comparisons confirm a significant increase in CD33 + cell populations relative to both wild-type KRAS and healthy controls.

Journal: iScience

Article Title: Hypoxic-immune axis orchestrates metastatic dissemination via HIF isoform imbalance in pancreatic neuroendocrine tumors

doi: 10.1016/j.isci.2025.114340

Figure Lengend Snippet: MDSC subsets in KRAS-mutated PNETs (A) Representative flow cytometry plots and histogram overlays demonstrate elevated CD11b + cell proportions in KRAS G12C patient blood samples compared to wild-type KRAS tumors and healthy controls. (B) Quantification shows a slight elevation in CD14 + cell frequency compared to wild-type KRAS, alongside a marked enrichment relative to healthy controls. (C) A moderate rise in CD15 + cell frequency in KRAS G12C samples versus wild-type KRAS, with a pronounced elevation compared to normal baseline levels. (D) Statistical comparisons confirm a significant increase in CD33 + cell populations relative to both wild-type KRAS and healthy controls.

Article Snippet: PerCP/Cyanine5.5 Anti-Human CD14 Antibody [M5E2] , Elabscience , E-AB-F1209J.

Techniques: Flow Cytometry